熱門資訊> 正文
ADMA Biologics偿还3000万美元循环信贷安排
2024-08-14 21:11
- ADMA Biologics (NASDAQ:ADMA) said it has repaid $30 million from its original $72.5 million revolving credit facility with Ares Capital.
- After the partial paydown, ADMA has reduced its total gross debt to $105 million, comprised of its existing $62.5 million term loan and $42.5 million now outstanding under its revolving credit facility.
- The company funded the partial paydown with cash on hand.
More on ADMA Biologics
- ADMA stock rallies 21% on raised guidance, earnings beat
- ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M
- Seeking Alpha’s Quant Rating on ADMA Biologics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
